Literature DB >> 19931338

IL-1 or TNF receptor gene deletion delays onset of encephalopathy and attenuates brain edema in experimental acute liver failure.

Chantal Bémeur1, Hong Qu, Paul Desjardins, Roger F Butterworth.   

Abstract

Previous reports suggested that brain-derived proinflammatory cytokines are involved in the pathogenesis of hepatic encephalopathy (HE) and brain edema in acute liver failure (ALF). To further address this issue, expression of interleukin-1beta (IL-1beta), tumor necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma) mRNAs were measured in the brains of mice with acute liver failure resulting from exposure to azoxymethane. In addition, time to severe encephalopathy (coma) was assessed in mice lacking genes coding for interferon-gamma, the tumor necrosis factor receptor-1 or the interleukin-1 type 1 receptor. Interleukin-1beta, tumor necrosis factor-alpha and interferon-gamma expression were quantified using RT-PCR. Significant increases in interleukin-1beta and tumor necrosis factor-alpha mRNA were observed in the frontal cortex of azoxymethane-treated wild-type mice at coma stages of encephalopathy. Interferon-gamma, however, could not be detected in the brains of these animals. Onset of severe encephalopathy (coma) and brain edema in ALF mice were significantly delayed in interleukin-1 type 1 receptor or tumor necrosis factor receptor-1 knockout mice. Deletion of the interferon-gamma gene, on the other hand, had no significative effect on the neurological status or brain water content of acute liver failure mice. These results demonstrate that toxic liver injury resulting from exposure to azoxymethane is associated with selective induction of proinflammatory cytokines in the brain and that deletion of tumor necrosis factor receptor-1 or interlukin-1 type 1 receptor delays the onset of coma and brain edema in this model of acute liver failure. These findings further support a role for selective brain-derived cytokines in the pathogenesis of the cerebral complications in acute liver failure and suggest that anti-inflammatory strategies could be beneficial in their prevention. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19931338     DOI: 10.1016/j.neuint.2009.11.010

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  34 in total

Review 1.  Changing face of hepatic encephalopathy: role of inflammation and oxidative stress.

Authors:  Amit S Seyan; Robin D Hughes; Debbie L Shawcross
Journal:  World J Gastroenterol       Date:  2010-07-21       Impact factor: 5.742

2.  Bile Acid Signaling Is Involved in the Neurological Decline in a Murine Model of Acute Liver Failure.

Authors:  Matthew McMillin; Gabriel Frampton; Matthew Quinn; Samir Ashfaq; Mario de los Santos; Stephanie Grant; Sharon DeMorrow
Journal:  Am J Pathol       Date:  2015-12-09       Impact factor: 4.307

Review 3.  Pathogenesis of hepatic encephalopathy: role of ammonia and systemic inflammation.

Authors:  Dominic R Aldridge; Edward J Tranah; Debbie L Shawcross
Journal:  J Clin Exp Hepatol       Date:  2014-06-30

Review 4.  Pathogenesis of hepatic encephalopathy and brain edema in acute liver failure.

Authors:  Roger F Butterworth
Journal:  J Clin Exp Hepatol       Date:  2014-07-09

Review 5.  Neuroinflammation in hepatic encephalopathy: mechanistic aspects.

Authors:  Arumugam R Jayakumar; Kakulavarapu V Rama Rao; Michael D Norenberg
Journal:  J Clin Exp Hepatol       Date:  2014-08-05

6.  TGR5 signaling reduces neuroinflammation during hepatic encephalopathy.

Authors:  Matthew McMillin; Gabriel Frampton; Richard Tobin; Giuseppina Dusio; Jenny Smith; Hope Shin; Karen Newell-Rogers; Stephanie Grant; Sharon DeMorrow
Journal:  J Neurochem       Date:  2015-09-10       Impact factor: 5.372

Review 7.  The concept of "the inflamed brain" in acute liver failure: mechanisms and new therapeutic opportunities.

Authors:  Roger F Butterworth
Journal:  Metab Brain Dis       Date:  2015-10-20       Impact factor: 3.584

8.  Gli1 activation and protection against hepatic encephalopathy is suppressed by circulating transforming growth factor β1 in mice.

Authors:  Matthew McMillin; Cheryl Galindo; Hae Yong Pae; Gabriel Frampton; Pier Luigi Di Patre; Matthew Quinn; Eric Whittington; Sharon DeMorrow
Journal:  J Hepatol       Date:  2014-07-18       Impact factor: 25.083

9.  Occludin is regulated by epidermal growth factor receptor activation in brain endothelial cells and brains of mice with acute liver failure.

Authors:  Feng Chen; Tomohide Hori; Norifumi Ohashi; Ann-Marie Baine; Christopher B Eckman; Justin H Nguyen
Journal:  Hepatology       Date:  2011-04       Impact factor: 17.425

10.  Marked potentiation of cell swelling by cytokines in ammonia-sensitized cultured astrocytes.

Authors:  Kakulavarapu V Rama Rao; Arumugam R Jayakumar; Xiaoying Tong; Veronica M Alvarez; Michael D Norenberg
Journal:  J Neuroinflammation       Date:  2010-10-13       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.